{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:22Z","timestamp":1787032882613,"version":"build-2736575974"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,17]]},"DOI":"10.7759\/cureus.20491","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T19:08:17Z","timestamp":1639768097000},"source":"Crossref","is-referenced-by-count":1,"title":["Rapidly Changing Serous Detachment During BRAF and MEK Inhibitor Therapy"],"prefix":"10.7759","author":[{"given":"Chisato","family":"Agata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohdai","family":"Kitamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Obata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15151","article-title":"Japanese Dermatological Association Guidelines: outlines of guidelines for cutaneous melanoma 2019","volume":"47","author":"Nakamura Y","year":"2020","unstructured":"Nakamura Y, Asai J, Igaki H, et al.. Japanese Dermatological Association Guidelines: outlines of guidelines for cutaneous melanoma 2019. J Dermatol. 2020, 47:89-103. 10.1111\/1346-8138.15151","journal-title":"J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies H","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, et al.. Mutations of the BRAF gene in human cancer. Nature. 2002, 417:949-54. 10.1038\/nature00766","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu169","article-title":"Transient MEK inhibitor-associated retinopathy in metastatic melanoma","volume":"25","author":"Urner-Bloch U","year":"2014","unstructured":"Urner-Bloch U, Urner M, Stieger P, et al.. Transient MEK inhibitor-associated retinopathy in metastatic melanoma. Ann Oncol. 2014, 25:1437-41. 10.1093\/annonc\/mdu169","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.07.016","article-title":"Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course\u00a0and management","volume":"119","author":"Gogas HJ","year":"2019","unstructured":"Gogas HJ, Flaherty KT, Dummer R, et al.. Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course\u00a0and management. Eur J Cancer. 2019, 119:97-106. 10.1016\/j.ejca.2019.07.016","journal-title":"Eur J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920944359","article-title":"Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy","volume":"12","author":"Booth AE","year":"2020","unstructured":"Booth AE, Hopkins AM, Rowland A, Kichenadasse G, Smith JR, Sorich MJ. Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy. Ther Adv Med Oncol. 2020, 12:1758835920944359. 10.1177\/1758835920944359","journal-title":"Ther Adv Med Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.05.038","article-title":"Clinical and Morphologic Characteristics of MEK inhibitor associated retinopathy: differences from central serous chorioretinopathy","volume":"124","author":"Francis JH","year":"2017","unstructured":"Francis JH, Habib LA, Abramson DH, et al.. Clinical and Morphologic Characteristics of MEK inhibitor associated retinopathy: differences from central serous chorioretinopathy. Ophthalmology. 2017, 124:1788-98. 10.1016\/j.ophtha.2017.05.038","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.06.018","article-title":"MEK inhibitor-associated retinopathy\u00a0(MEKAR) in metastatic melanoma: long-term ophthalmic effects","volume":"65","author":"Urner-Bloch U","year":"2016","unstructured":"Urner-Bloch U, Urner M, Jaberg-Bentele N, Frauchiger AL, Dummer R, Goldinger SM. MEK inhibitor-associated retinopathy\u00a0(MEKAR) in metastatic melanoma: long-term ophthalmic effects. Eur J Cancer. 2016, 65:130-8. 10.1016\/j.ejca.2016.06.018","journal-title":"Eur J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002965","article-title":"Rapid fluctuation of subretinal fluid on encorafenib and binimetinib","volume":"40","author":"Li AS","year":"2020","unstructured":"Li AS, Leng T, Nagpal S, Liao YJ. Rapid fluctuation of subretinal fluid on encorafenib and binimetinib. Retina. 2020, 40:e66-7. 10.1097\/IAE.0000000000002965","journal-title":"Retina"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78973-rapidly-changing-serous-detachment-during-braf-and-mek-inhibitor-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:34:19Z","timestamp":1707489259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78973-rapidly-changing-serous-detachment-during-braf-and-mek-inhibitor-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.20491","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,17]]}}}